Ling Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ling Kong has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Changqing Liu
Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, People’s Republic of China
1 shared publication- Guohua Ni
Hefei Institutes of Physical Science, Chinese Academy of Sciences
1 shared publication - Jingjing Zha
Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, People’s Republic of China
1 shared publication Tao Sun
Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, People’s Republic of China
1 shared publication
Latest Publications
- 10 October 2024
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (6) , 065036
Cold plasma irradiation inhibits skin cancer via ferroptosis
Cold atmospheric plasma (CAP) has been extensively utilized in medical treatment, particularly in cancer therapy. However, the underlying mechanism of CAP in skin cancer treatment remains elusive. In this study, we established a skin cancer model using CAP treatment in vitro. Also, we established the Xenograft experiment model in vivo. The results demonstrated that treatment with CAP induced ferroptosis, resulting in a significant reduction in the viability, migration, and invasive capacities of A431 squamous cell carcinoma, a type of skin cancer. Mechanistically, the significant production of reactive oxygen species (ROS) by CAP induces DNA damage, which then activates Ataxia-telangiectasia mutated (ATM) and p53 through acetylation, while simultaneously suppressing the expression of Solute Carrier Family 7 Member 11 (SLC7A11). Consequently, this cascade led to the down-regulation of intracellular Glutathione peroxidase 4 (GPX4), ultimately resulting in ferroptosis. CAP exhibits a favorable impact on skin cancer treatment, suggesting its potential medical application in skin cancer therapy.
- 10 October 2024
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (6) , 065036
Cold plasma irradiation inhibits skin cancer via ferroptosis
Cold atmospheric plasma (CAP) has been extensively utilized in medical treatment, particularly in cancer therapy. However, the underlying mechanism of CAP in skin cancer treatment remains elusive. In this study, we established a skin cancer model using CAP treatment in vitro. Also, we established the Xenograft experiment model in vivo. The results demonstrated that treatment with CAP induced ferroptosis, resulting in a significant reduction in the viability, migration, and invasive capacities of A431 squamous cell carcinoma, a type of skin cancer. Mechanistically, the significant production of reactive oxygen species (ROS) by CAP induces DNA damage, which then activates Ataxia-telangiectasia mutated (ATM) and p53 through acetylation, while simultaneously suppressing the expression of Solute Carrier Family 7 Member 11 (SLC7A11). Consequently, this cascade led to the down-regulation of intracellular Glutathione peroxidase 4 (GPX4), ultimately resulting in ferroptosis. CAP exhibits a favorable impact on skin cancer treatment, suggesting its potential medical application in skin cancer therapy.